A Florida compounding pharmacy is among the companies that were sued last week by Eli Lilly for allegedly selling unregulated and unapproved versions of a weight loss drug.

The Wells Pharmacy Network along with 9 other medical spas, wellness centers and compounding pharmacies are accused of selling drug preparations that contain Tirzepatide, according to media reports.

“These entities should be stopped from providing drug products in violation of consumer protection laws, particularly where they promise their patients that their drugs offer the same safety profile and clinical benefits as Mounjaro,” an Eli Lilly spokesperson said.

Click Here To Read The Full Article